[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TheStockerMan
"$HIMS OFFICIALLY LAUNCHES MENOPAUSE UNDER THE HERS BRAND Estradiol pill or patch Progesterone pill Estradiol vaginal cream Stock up XX% today after management revealed they expect the HERS business to reach $X BILLION in revenue by end of 2026. This is massive the menopause market alone is valued at $22B+ annually in the U.S. with over XX million women currently experiencing symptoms. Hims & Hers is now directly targeting this underserved demographic with a trusted telehealth platform and proven subscription model. Q2 revenue: $299M (+49% YoY) Gross margins: XX% Cash on hand: $235M+ zero debt"
X Link @TheStockerMan 2025-10-15T21:03Z XXX followers, XXX engagements
"@skywalker90210 6$ imo. Still way too cheap $FUBO trading at under 1x forward sales while peers in streaming/sports entertainment trade between 23x with 20%+ YoY revenue growth improving ad margins + DOJ catalyst ahead"
X Link @TheStockerMan 2025-10-14T18:12Z XXX followers, XXX engagements
"TRUMP SAYS HE WOULD MAKE A DEAL ON AFFORDABLE CARE ACT SUBSIDIES This is the news we needed $OSCR 🚀 Cheers to those who held strong the storys just getting started"
X Link @TheStockerMan 2025-10-06T20:39Z XXX followers, XXX engagements
"Im buying more $FUBO tomorrow. On September 30th shareholders officially approved the merger deal a major step forward that now just awaits DOJ approval which could come very soon. Even without the merger catalyst $FUBO looks deeply undervalued: Revenue up +24% YoY last quarter ARPU growing steadily Operating loss shrinking by over XX% YoY Trading at less than 1x sales far below sector peers Once the DOJ gives the green light this could easily re-rate toward fair value"
X Link @TheStockerMan 2025-10-14T03:48Z XXX followers, 2947 engagements
"My next few paychecks are going straight into $LMND and $ZETA both look way too undervalued right now. $LMND (Lemonade): Trading around 1.5x sales compared to peers like $ALL at 1.2x but growing much faster (YoY revenue growth +25%). In-force premium up XX% YoY and loss ratio dropped from XX% to XX% showing improving underwriting efficiency. With over $900M in cash and no debt theyre positioned perfectly for when insurance tech sentiment flips. $ZETA (Zeta Global): Revenue up XX% YoY last quarter with adjusted EBITDA margin at XX% showing both growth and profitability trajectory. Currently"
X Link @TheStockerMan 2025-10-08T00:01Z XXX followers, XXX engagements
"updated long-term portfolio: $HIMS XX% $TSLA XX% $SOFI XX% $AMD XX% $OSCR XX% $UNH X% $PLTR X% $ZETA X% $LMND X% Im planning to grow my $LMND position over the next few weeks I see it setting up for a breakout to $70+ with margins expanding quarter over quarter. In my other account Im also holding names like $BMNR $OPEN $NVO $FUBO and $JD all with solid upside potential heading into 2025"
X Link @TheStockerMan 2025-10-13T18:38Z XXX followers, XXX engagements